Editorial commentary: The how of polymerase chain reaction testing for bordetella pertussis depends on the why

Clinical Infectious Diseases

Volumn 56, Issue 3, 2013, Pages 332-334

  McIntyre, Peter B ^a,b,e   Sintchenko, Vitali ^c,d,e  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e NATIONAL CENTRE FOR IMMUNISATION RESEARCH AND SURVEILLANCE   (Australia)

Author keywords

Bordetella pertussis; PCR

Indexed keywords

BORDETELLA PERTUSSIS; HOSPITALIZATION; HUMAN; IMMUNIZATION; INCIDENCE; NOTE; PERTUSSIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; BORDETELLA; EPIDEMIC; ISOLATION AND PURIFICATION;

BORDETELLA; BORDETELLA PERTUSSIS; DISEASE OUTBREAKS; HUMANS; WHOOPING COUGH;

EID: 84872360958     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis897     Document Type: Note

References (27)

1. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18:326-82.
2. Zhang L, Prietsch SO, Axelsson I, Halperin SA. Acellular pertussis vaccines for preventing whooping cough in children. Cochrane Database Syst Rev 2011; CD001478.
3. Heininger U, Schmidt-Schlapfer G, Cherry JDStehr K. Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics 2000;105; e31.
4. Ward JI, Cherry JD, Chang SJ, et al. Bordetella pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT). Clin Infect Dis 2006; 43:151-7.
5. Cherry JD. Why do pertussis vaccines fail? Pediatrics 2012; 129:968-70.
6. Wirsing von König CH, Rott H, Bogaerts H, Schmitt HJ. A serologic study of organisms possibly associated with pertussis-like coughing. Pediatr Infect Dis J 1998; 17: 645-9.
7. Knorr L, Fox JD, Tilley PAG, Ahmed- Bentley J. Evaluation of real-time PCR for diagnosis of Bordetella pertussis infection. BMC Infect Dis 2006; 6:62. doi:10.1186/ 1471-2334-6-62.
8. Fisman DN, Tang P, Hauck T, et al. Pertussis resurgence in Toronto, Canada: a population-based study including test-incidence feedback modeling. BMC Public Health 2011; 11:694.
9. Waters V, Jamieson F, Richardson SE, Finkelstein M, Wormsbecker A, Halperin SA. Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged children. Pediatr Infect Dis J 2009; 28:582-7.
10. Leviano FA, Reynolds MA, Waring AL, et al. Issues associated with and recommendations for using PCR to detect outbreaks of pertussis. J Clin Microbiol 2002; 40:2801-5.
11. Cherry JD, Tan T, Wirsing von König CH, et al. Clinical definitions of pertussis: summary of a Global Pertussis Initiative Roundtable Meeting, February 2011. Clin Infect Dis 2012; 54:1756-64.
12. Nieves DJ, Singh J, Ashouri N, McGuire T, Adler-Shohet FC, Arrieta AC. Clinical and laboratory features of pertussis in infants at the onset of a California epidemic. J Pediatr 2011; 159:1044-6.
13. Horby P, MacIntyre CR, McIntyre PB, et al. A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods. Epidemiol Infect 2005; 133: 229-36.
14. Rodgers L, Martin SW, Cohn A, et al. Epidemiologic and laboratory features of a large outbreak of pertussis-like illness associated with co-circulating Bordetella holmesii and Bordetella pertussis: Ohio, 2010-2011. Clin Infect Dis 2013; 56:322-31.
15. Winter K, Harriman K, Zipprich J, et al. California pertussis epidemic, 2010. J Pediatr 2012; [Epub ahead of print].
16. Kamiya H, Otsuka N, Ando Y, et al. Transmission of Bordetella holmesii during pertussis outbreak, Japan. Emerg Infect Dis 2012; 18:1166-9.
17. Yih WK, Silva EA, Ida J, Harrington N, Lett SMGeorge H. Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms. Emerg Infect Dis 1999; 5:441-3.\
18. Njamkepo E, Bonacorsi S, Debruyne M, Gibaud SA, Guilot S, Guiso N. Significant finding of Bordetella holmesii DNA in nasopharyngeal samples from French patients with suspected pertussis. J Clin Microbiol 2011; 49:4347-8.
19. He Q, Viljanen MK, Arvilommi H, Aittanen BMertsola J. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA 1998; 280:635-7.
20. Cherry JD, Seaton BL. Patterns of Bordetella parapertussis respiratory illnesses: 2008- 2010. Clin Infect Dis 2012; 54:534-7.
21. Sheridan SL, Ware RS, Grimwood K, Lambert SB. Number and order of wholecell pertussis vaccines in infancy and disease protection. JAMA 2012; 308:454-6.
22. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med 2012; 367:1012-9.
23. David S, van Furth R, Mooi FR. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model. Vaccine 2004; 22:1892-8.
24. de Gouw D, Diavatopoulos DA, Bootsma HJ, Hermans PW, Mooi FR. Pertussis: a matter of immune modulation. FEMS Microbiol Rev 2011; 35:441-74. .
25. Roorda L, Buitenwerf J, Ossewaarde JM, van der Zee A. A real-time PCR assay with improved specificity for detection and discrimination of all clinically relevant Bordetella species by the presence and distribution of three insertion sequence elements. BMC Res Notes 2011; 4:11.
26. Sibley CD, Peirano G, Church DL. Molecular methods for pathogen and microbial community detection and characterization: current and potential application in diagnostic microbiology. Infect Genet Evol 2012; 12:505-21.
27. Cherry JD, Paddock CD, Greer PW, Heininger U. The respiratory pathology in infants with sudden unexpected deaths in whom respiratory specimens were initially PCR-positive or PCR-negative for Bordetella pertussis. Infection 2011; 39:545-8.